Shell Asset Management Co. Has $701,000 Stock Position in Corteva, Inc. (NYSE:CTVA)

Shell Asset Management Co. decreased its position in Corteva, Inc. (NYSE:CTVA) by 2.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,310 shares of the company’s stock after selling 337 shares during the period. Shell Asset Management Co.’s holdings in Corteva were worth $701,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in CTVA. JPMorgan Chase & Co. raised its holdings in Corteva by 6.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company’s stock valued at $270,764,000 after acquiring an additional 288,885 shares in the last quarter. Burney Co. raised its holdings in shares of Corteva by 6.3% in the 4th quarter. Burney Co. now owns 4,505 shares of the company’s stock worth $257,000 after buying an additional 266 shares in the last quarter. Procyon Advisors LLC raised its holdings in shares of Corteva by 1.6% in the 4th quarter. Procyon Advisors LLC now owns 13,413 shares of the company’s stock worth $764,000 after buying an additional 213 shares in the last quarter. Merit Financial Group LLC raised its holdings in shares of Corteva by 55.9% in the 4th quarter. Merit Financial Group LLC now owns 5,363 shares of the company’s stock worth $305,000 after buying an additional 1,922 shares in the last quarter. Finally, Brooklyn Investment Group raised its holdings in shares of Corteva by 9.9% in the 4th quarter. Brooklyn Investment Group now owns 2,744 shares of the company’s stock worth $156,000 after buying an additional 248 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 26,560 shares of the firm’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. This trade represents a 70.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.14% of the company’s stock.

Corteva Stock Up 0.4%

Shares of CTVA opened at $68.58 on Monday. The firm has a market capitalization of $46.78 billion, a price-to-earnings ratio of 53.16, a PEG ratio of 1.68 and a beta of 0.72. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The business’s fifty day moving average price is $61.61 and its two-hundred day moving average price is $60.98. Corteva, Inc. has a 52 week low of $50.01 and a 52 week high of $69.28.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $0.88 by $0.25. The firm had revenue of $4.42 billion for the quarter, compared to analyst estimates of $4.56 billion. Corteva had a return on equity of 7.19% and a net margin of 5.36%. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period last year, the company earned $0.89 EPS. On average, analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 2nd will be given a $0.17 dividend. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.99%. Corteva’s payout ratio is 41.46%.

Analyst Ratings Changes

CTVA has been the subject of a number of recent research reports. KeyCorp increased their target price on Corteva from $71.00 to $72.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Citigroup increased their target price on Corteva from $75.00 to $78.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Wells Fargo & Company increased their target price on Corteva from $73.00 to $79.00 and gave the stock an “overweight” rating in a report on Monday, May 12th. UBS Group increased their price target on Corteva from $74.00 to $76.00 and gave the stock a “buy” rating in a research report on Thursday, May 8th. Finally, Bank of America increased their price target on Corteva from $69.00 to $73.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average price target of $70.50.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.